Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oishi, N.
Right arrow Articles by Fukuyama, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oishi, N.
Right arrow Articles by Fukuyama, H.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow Hallucinations
NEUROLOGY 2005;65:1708-1715
© 2005 American Academy of Neurology

Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations

N. Oishi, MD, F. Udaka, MD, M. Kameyama, MD, N. Sawamoto, MD, K. Hashikawa, MD and H. Fukuyama, MD

From Human Brain Research Center (Drs. Oishi, Sawamoto, Hashikawa, and Fukuyama), Kyoto University Graduate School of Medicine; and Department of Neurology (Drs. Oishi, Udaka, and Kameyama), Sumitomo Hospital, Osaka, Japan.

Address correspondence and reprint requests to Dr. Naoya Oishi, Human Brain Research Center, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan; e-mail: noishi{at}kuhp.kyoto-u.ac.jp

Background: Patients with Parkinson disease (PD) often experience visual hallucinations (VH) with retained insight (nonpsychotic) but the precise mechanism remains unclear.

Objective: To clarify which neural substrates participate in nonpsychotic VH in PD, the authors evaluated regional cerebral blood flow (rCBF) changes in patients with PD and VH.

Methods: The authors compared 24 patients with PD who had nonpsychotic VH (hallucinators) and 41 patients with PD who had never experienced VH (non-hallucinators) using SPECT images with N-isopropyl-p-[123I]iodoamphetamine. There were no significant differences in age, sex, duration of disease, doses of PD medications, Hoehn and Yahr scale, or Mini-Mental State Examination (MMSE) scores between the two groups. The rCBF data were analyzed using statistical parametric mapping (SPM).

Results: The rCBF in the right fusiform gyrus was lower in the hallucinators than in the non-hallucinators (corrected p < 0.05 at cluster levels). The hallucinators revealed higher rCBF in the right superior and middle temporal gyri than the non-hallucinators (uncorrected p < 0.001). These significant differences were demonstrated after MMSE scores and duration of disease, which are the relevant factors associated with VH, were covariated out.

Conclusions: Nonpsychotic visual hallucinations in Parkinson disease (PD) may be associated with hypoperfusion in the right fusiform gyrus and hyperperfusion in the right superior and middle temporal gyri. These temporal regions are important for visual object recognition and these regional cerebral blood flow changes are associated with inappropriate visual processing and are responsible for nonpsychotic visual hallucinations in PD.

Supported in part by Grants-in-Aid for Scientific Research (B) 14370205 from the Ministry of Education, Culture, Sports, Science and Technology, and General Research Grant "Science of Mind" and "Aging and Health" from the Ministry of Health, Labor and Welfare.

Disclosure: The authors report no conflicts of interest.

Received January 18, 2005. Accepted in final form August 15, 2005.




This article has been cited by other articles:


Home page
 BrainHome page
A. M. Meppelink, B. M. de Jong, R. Renken, K. L. Leenders, F. W. Cornelissen, and T. van Laar
Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations
Brain, November 1, 2009; 132(11): 2980 - 2993.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
F. Manganelli, C. Vitale, G. Santangelo, C. Pisciotta, R. Iodice, A. Cozzolino, R. Dubbioso, M. Picillo, P. Barone, and L. Santoro
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease
Brain, September 1, 2009; 132(9): 2350 - 2355.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
F. Toal, O. J. N. Bloemen, Q. Deeley, N. Tunstall, E. M. Daly, L. Page, M. J. Brammer, K. C. Murphy, and D. G. M. Murphy
Psychosis and autism: magnetic resonance imaging study of brain anatomy
The British Journal of Psychiatry, May 1, 2009; 194(5): 418 - 425.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
P. H. Lee, S. W. Yong, and Y.-S. An
Changes in Cerebral Glucose Metabolism in Patients with Parkinson Disease with Dementia After Cholinesterase Inhibitor Therapy
J. Nucl. Med., December 1, 2008; 49(12): 2006 - 2011.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
C. Tessa, M. Giannelli, R. Della Nave, C. Lucetti, C. Berti, A. Ginestroni, U. Bonuccelli, and M. Mascalchi
A Whole-Brain Analysis in De Novo Parkinson Disease
AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 674 - 680.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
H. Oka, M. Yoshioka, K. Onouchi, M. Morita, S. Mochio, M. Suzuki, T. Hirai, Y. Ito, and K. Inoue
Characteristics of orthostatic hypotension in Parkinson's disease
Brain, August 2, 2007; (2007) awm174v1.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.